Trials / Unknown
UnknownNCT05859581
The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer
To Explore the Value of Colon MRI in Assessing the Status of Retroperitoneal Resection Margin Following Beyond Complete Mesocolic Excision Surgery for Advanced Colon Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to explore the value of colon MRI in assessing the status of retroperitoneal resection margin (RPRM) for advanced colon cancer. The main questions it aims to answer are: * Concordance between MRI suspected RPRM positive and pathologically confirmed positive. * Can RPRM-positive patients undergo beyond complete mesocolic excision (CME) surgery in order to achieve R0 resection? Participants will undergo colon MRI examination and once MRI suspects RPRM positive, they will receive beyond CME surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Beyond complete mesocolic excision surgery | If the participants were diagnosed with positive retroperitoneal resection margin (RPRM), they underwent beyond complete mesocolic excision surgery to ensure the R0 resection. |
Timeline
- Start date
- 2023-04-02
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2023-05-16
- Last updated
- 2023-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05859581. Inclusion in this directory is not an endorsement.